Home » Topics » BioWorld Science

BioWorld Science
RSS

Blocking PAI-1 inhibits experimental PTSD development

Dec. 29, 2021

Emendo Biotherapeutics develops CRISPR-based ex-vivo gene editing strategy for ELANE neutropenia

Dec. 29, 2021

Roche identifies new antibacterials

Dec. 29, 2021

TOPADUR Pharma identifies dual PDE5A inhibitors/soluble guanylate cyclase activators

Dec. 29, 2021

New USP30 inhibitors identified at Mission Therapeutics

Dec. 29, 2021

New RIPK1 inhibitors discovered at Sanofi

Dec. 29, 2021

Boehringer Ingelheim, Vanderbilt University describe mutant GTPase KRAS inhibitors

Dec. 29, 2021

Red seaweed-derived iota-carrageenan shows in vitro activity against SARS-CoV-2 and VOCs

Dec. 29, 2021

New triglyceride-mimetic structure-gated prodrug nanoplatform for precise tumor drug delivery

Dec. 29, 2021

Discovery of novel ABCB1 inhibitors that can help overcome ABCB1-mediated chemotherapy resistance

Dec. 29, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...